
CAS 1070773-09-9
:Ordinare per
Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
7 prodotti.
Ref: IN-DA01ENVM
1mg50,00€2mg54,00€5mg68,00€10mg106,00€25mg160,00€50mg180,00€100mg299,00€250mg653,00€Ref: 4Z-R-161002
5mgPrezzo su richiesta10mg1.942,00€25mg3.580,00€50mg5.764,00€100mgPrezzo su richiestaRK33
CAS:"RK33 is a DDX3 inhibitor causing G1 arrest, apoptosis, and radiation sensitization in DDX3-overexpressing cells."Formula:C23H20N6O3Purezza:99.04% - 99.72%Colore e forma:SolidPeso molecolare:428.44RK 33
CAS:Prodotto controllatoApplications RK 33 is an inhibitor of DDX3, an ATP-dependent RNA helicase (1). Aberrant regulation of DDX3 is related to various diseases such as prostate and breast cancer (2). RK 33 was shown to decrease proliferation of prostate cancer cells and induced a G1 phase cell-cycle arrest (2).
References (1) Botlagunta, M. et al.: PLoS One. 6, e17563 (2011) (2) Xie, M., et al.: Cancer Res. 76, 6340 (2016)Formula:C23H20N6O3Colore e forma:NeatPeso molecolare:428.44RK-33
CAS:RK-33 is a small molecule inhibitor, which is synthesized as a chemical compound. It functions by targeting and inhibiting the activity of DDX3, a DEAD-box RNA helicase, which plays a crucial role in the modulation of RNA biogenesis and translation processes. By interfering with DDX3, RK-33 disrupts processes essential for the proliferation of certain cancer cells, making it a significant focus in cancer research.Formula:C23H20N6O3Purezza:Min. 95%Peso molecolare:428.44 g/mol





